Mean Platelet Volume and STEMI Clinical Risk Scores in Prediction of Impaired Myocardial Perfusion In Acute STEMI Patients Undergoing Primary Percutaneous Coronary Intervention.

Assiut University

Status: Completed

Conditions: No-Reflow Phenomenon

Treatments: Other: Mean platelet volume, lymphocyte number, STEMI clinical risk scores

Study type: Observational

Funder types: Other

Identifiers

NCT04785209

Prediction of No reflow

Details and patient eligibility

About

Predicting no reflow in ppci of STEMI patients using mean platelet volume together with STEMI clinical risk scores

Enrollment: 640 patients

Sex: All

Ages: 16+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• patients presenting with acute STEMI, within 24 hours of symptoms, fulfilling criteria for PPCI protocol in our facility

Exclusion criteria

• patients presenting more than 24 hours of symptoms onset
• patients not eligible for PPCI program in our facility

Trial design

640 participants in 2 patient groups

No complication

Description:

Thrombolysis in myocardial infarction flow grade III flow after PPCI, mean platelet volume, lymphocyte ratio, detailed echo within 24 hrs of admission, clinical STEMI risk scores

Treatment:

Other: Mean platelet volume, lymphocyte number, STEMI clinical risk scores

No reflow

Description:

No reflow phenomenon after pci on STEMI patients, mean platelet volume, lymphocyte ratio, detailed echo within 24 hrs of admission, clinical STEMI risk scores

Treatment:

Other: Mean platelet volume, lymphocyte number, STEMI clinical risk scores